Next Article in Journal
Oxidative Stress and MicroRNAs in Vascular Diseases
Next Article in Special Issue
Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
Previous Article in Journal
Potential Targets for Colorectal Cancer Prevention
Previous Article in Special Issue
The Role of Thyroid Hormone Signaling in the Prevention of Digestive System Cancers
Int. J. Mol. Sci. 2013, 14(9), 17304-17318; doi:10.3390/ijms140917304
Article

Low Amount of Salinomycin Greatly Increases Akt Activation, but Reduces Activated p70S6K Levels

1
, 1
, 2
, 3
 and 1,*
Received: 8 July 2013; in revised form: 12 August 2013 / Accepted: 13 August 2013 / Published: 22 August 2013
(This article belongs to the Special Issue Molecular Bases of Cancer Research)
View Full-Text   |   Download PDF [1523 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: The present study identified a novel salinomycin (Sal)-sensitization mechanism in cancer cells. We analyzed the signal proteins Akt, Jnk, p38, Jak, and Erk1/2 in cancer cell lines that had arrested growth following low amounts of Sal treatment. We also tested the signal molecules PI3K, PDK1, GSK3β, p70S6K, mTOR, and PTEN to analyze the PI3K/Akt/mTOR pathway. The results showed that Sal sensitization positively correlates with large reductions in p70S6K activation. Interestingly, Akt was the only signal protein to be significantly activated by Sal treatment. The Akt activation appeared to require the PI3K pathway as its activation was abolished by the PI3K inhibitors LY294002 and wortmannin. The Akt activation by Sal was conserved in the other cell lines analyzed, which originated from other organs. Both Akt activation and C-PARP production were proportionally increased with increased doses of Sal. In addition, the increased levels of pAkt were not reduced over the time course of the experiment. Co-treatment with Akt inhibitors sensitized the Sal-treated cancer cells. The results thereby suggest that Akt activation is increased in cells that survive Sal treatment and resist the cytotoxic effect of Sal. Taken together; these results indicate that Akt activation may promote the resistance of cancer cells to Sal.
Keywords: Salinomycin; Akt; p70S6K; mTOR; LY294002; wortmannin; cancer Salinomycin; Akt; p70S6K; mTOR; LY294002; wortmannin; cancer
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Kim, J.-H.; Choi, A.-R.; Kim, Y.K.; Kim, H.S.; Yoon, S. Low Amount of Salinomycin Greatly Increases Akt Activation, but Reduces Activated p70S6K Levels. Int. J. Mol. Sci. 2013, 14, 17304-17318.

AMA Style

Kim J-H, Choi A-R, Kim YK, Kim HS, Yoon S. Low Amount of Salinomycin Greatly Increases Akt Activation, but Reduces Activated p70S6K Levels. International Journal of Molecular Sciences. 2013; 14(9):17304-17318.

Chicago/Turabian Style

Kim, Ju-Hwa; Choi, Ae-Ran; Kim, Yong K.; Kim, Hyung S.; Yoon, Sungpil. 2013. "Low Amount of Salinomycin Greatly Increases Akt Activation, but Reduces Activated p70S6K Levels." Int. J. Mol. Sci. 14, no. 9: 17304-17318.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert